Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Onglyza
Onglyza
CVS shucking more drugs from its coverage list
Fierce Pharma
Fri, 11/9/12 - 11:26 am
CVS
pharmacy benefits
Allergan
Lumigan
Androgel
Abbott Labs
Pfizer
Genotropin
Bristol-Myers Squibb
AstraZeneca
Onglyza
Bristol-Myers Squibb: Outstanding Pipeline Makes It Most Attractive Among Large Pharmaceuticals
Seeking Alpha
Fri, 02/25/11 - 12:06 am
pipelines
Bristol-Myers Squibb
Reyataz
HIV
Baraclude
Orencia
rheumatoid arthritis
Sprycel
chronic myeloid leukemia
Onglyza
diabetes
hepatitis B
FDA approves kidney disease label for Onglyza
Yahoo/AP
Wed, 02/23/11 - 10:06 pm
kidney disease
FDA
Onglyza
A Biotech Roller Coaster
Motley Fool
Sat, 01/8/11 - 11:57 am
Lexicon Pharmaceuticals
diabetes
LX4211
Merck
obesity
Amylin
Januvia
Onglyza
Bristol-Myers Squibb
AstraZeneca
Bristol-Myers gets drug approvals, awaits more
Yahoo/AP
Sat, 10/23/10 - 12:42 pm
Bristol-Myers Squibb
pegylated interferon lambda
hepatitis C
Sprycel
chronic myeloid leukemia
Onglyza
You Can Blame Bristol-Myers’ Layoffs on Failed Launch of Me-Too Diabetes Drug
BNET Pharma
Fri, 09/24/10 - 11:42 am
layoffs
Bristol-Myers Squibb
Onglyza
diabetes
blood thinners
Plavix
It's All About the Future for Amylin
Motley Fool
Thu, 07/22/10 - 03:49 pm
Amylin
Bydureon
Byetta
diabetes
Novo Nordisk
Victoza
Merck
Januvia
Takeda
Actos
Onglyza
AstraZeneca
If Avandia falls, which diabetes meds fill the gap?
Fierce Pharma
Wed, 07/14/10 - 12:09 pm
diabetes
GSK
Avandia
Actos
Takeda
Merck
Januvia
Novo Nordisk
Victoza
Eli Lilly
Byetta
Amylin
Onglyza
AstraZeneca
Bristol-Myers Squibb
Bristol combination diabetes drug under review
Yahoo/AP
Wed, 03/17/10 - 11:00 am
diabetes
Bristol-Myers Squibb
Onglyza
FDA
AstraZeneca
Bristol-Myers' Damp Squib: Diabetes Drug Onglyza Nets Only $6M in Q4
BNET Pharma
Wed, 02/17/10 - 09:06 am
diabetes
Onglyza
Bristol-Myers Squibb
Effient and Onglyza Start Slow—And That May Not Be A Bad Thing
InVivo
Mon, 10/26/09 - 11:58 am
Effient
Onglyza
diabetes
Eli Lilly
Bristol-Myers Squibb
Daiichi Sankyo
Prasugrel
EU approves AstraZeneca, Bristol diabetes drug
Marketwatch
Mon, 10/5/09 - 11:21 am
AstraZeneca
Bristol-Myers Squibb
Europe
diabetes
Onglyza
Effient and Onglyza Launches "Sluggish"; Multaq More Hopeful
BNET Pharma
Mon, 09/21/09 - 05:23 pm
Effient
Onglyza
diabetes
Eli Lilly
AstraZeneca
Bristol-Myers Squibb
Onglyza and the Type 2 Diabetes Approval Path: The Map is Still Sketchy
InVivo
Wed, 08/19/09 - 07:27 am
diabetes
Onglyza
Bristol-Myers Squibb
AstraZeneca
New Diabetes Drug Could Give Januvia Stiff Competition
Seeking Alpha
Tue, 08/4/09 - 07:50 am
Merck
diabetes
Januvia
Bristol-Myers Squibb
AstraZeneca
Takeda
Forest Labs
OSI Pharmaceuticals
Novartis
Onglyza
FDA approves new diabetes drug Onglyza
Yahoo/AP
Fri, 07/31/09 - 02:56 pm
FDA
diabetes
AstraZeneca
Onglyza
Bristol-Myers Squibb
Bristol exec hints of Onglyza launch strategy
Fierce Pharma
Fri, 07/10/09 - 09:59 am
Bristol-Myers Squibb
Onglyza
AstraZeneca
Looking for a Sliver of the Me-Too Pie
Motley Fool
Sat, 06/27/09 - 09:59 am
Bristol-Myers Squibb
AstraZeneca
Onglyza
AstraZeneca says Onglyza gets positive opinion
Marketwatch
Fri, 06/26/09 - 10:37 am
AstraZeneca
diabetes
Onglyza
CHMP
EU panel gives positive recommendation to Bristol-Myers and AstraZeneca's Onglyza for diabetes
Yahoo/AP
Thu, 06/25/09 - 03:21 pm
Europe
diabetes
Bristol-Myers Squibb
Onglyza
AstraZeneca
Pages
« first
‹ previous
1
2
3
next ›
last »